DEA Reviews Bulk Marijuana Making for Science Lab
Published Date: 3/27/2025
Notice
Summary
Ohana Bio Pharma, LLC wants to grow and make a lot of marijuana for science and medicine. The DEA is checking their application to make sure they follow the rules. If approved, this could help researchers get more marijuana for important studies, with no immediate cost changes announced.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
DEA review could increase research supply
If you are a researcher or research institution, Ohana Bio Pharma, LLC has applied to be registered by the Drug Enforcement Administration to manufacture marihuana in bulk as a Schedule I controlled substance for scientific and medical research. The DEA is evaluating the application under its registration program, and if approved researchers may gain increased access to research-grade marihuana. The notice does not announce any immediate changes to costs or prices.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in